Pharmaceutical News

RSS

Marijuana edibles carry risk and side effects for patients with cardiovascular disease

As marijuana legalization sweeps North America, use of the substance has been on the rise, and the public's attitude is shifting. An increasing number of people believe that "weed" is the safest recreational drug, one that carries health benefits that outweigh its risks.

11 Feb 2019

MDMA users have higher levels of empathy than other drug users

Long-term MDMA users have higher levels of empathy than cannabis and other drugs users, new research suggests.

11 Feb 2019

New findings could provide novel approach to target and destroy cancer cells

An unexpected finding in pre-clinical platelet studies by Baker Institute researchers could provide a novel approach to targeting and destroying difficult-to-treat cancer cells, providing new therapeutic options for a range of cancers.

11 Feb 2019

New cancer drug that acts as ‘Trojan horse’ shows promise in patients with various cancers

A brand new type of cancer drug that acts as a 'Trojan horse' to get inside tumor cells has shown promise in patients with six different cancer types.

11 Feb 2019

'Trojan horse' drug shows promise for untreatable cancers

A new cancer drug that uses a ‘Trojan horse’ approach to destroy cancer cells from within has shown promising results for patients with untreatable cancers.

8 Feb 2019

Misinformation is causing measles cases to rise worldwide

Misinformation and anti-vaccination groups have caused a rise in cases of vaccine-preventable viral disease measles around the world, according to the WHO.

8 Feb 2019

FDA takes initiative to adopt modern technologies for enhancing security of the drug supply chain

A key element of the U.S. Food and Drug Administration's mission is focused on helping to ensure that all products we regulate, including drugs available to consumers, are safe and of high quality. This means working to ensure greater accountability in our nation's drug supply chain.

8 Feb 2019

Drug that reverses blood thinning effects stops acute life-threatening bleeding

A drug that reverses the blood thinning effects of factor Xa inhibitors effectively stopped acute life-threatening bleeding in patients taking a factor Xa inhibitor blood thinner drug, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

8 Feb 2019

Study finds underutilization of aspirin to prevent colorectal cancer in high risk patients

Colorectal cancer is the third most common cause of cancer deaths in the United States and advanced colorectal polyps are a major risk factor.

7 Feb 2019

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past two years, the result of its actions to streamline a cumbersome process and combat anti-competitive practices.

7 Feb 2019

Blood-clotting factor may cause Alzheimer's disease

A protein known for its role in forming blood clots has been found to cause the characteristic cognitive decline of Alzheimer's disease.

7 Feb 2019

Combination treatment lowers risk of ischemic stroke recurrence

Stroke survivors taking a combination of the blood thinner cilostazol with aspirin or clopidogrel had a lower risk of ischemic stroke recurrence than those who received aspirin or clopidogrel alone, according to late breaking science presented at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.

7 Feb 2019

New physical effect could lead to advancements in personalized pharmaceuticals

A new physical effect has been demonstrated at the University of Bath after 40 years of pursuit by physicists around the world, which could lead to advancements in chemical manufacturing efficiency, miniaturization and quality control in personalized pharmaceuticals.

7 Feb 2019

Review: Antibiotic development has increased, but inadequate

While the pipeline of new antibiotics has improved over the past six years, momentum in the development of new infection-fighting agents remains inadequate and could take a significant downturn without new incentives, a report released in Clinical Infectious Diseases shows.

7 Feb 2019

NSAID pretreatment promotes cardiorenal syndrome in heart failure

Non-steroidal anti-inflammatory drugs, or NSAIDs, are widely known as pain-killers and can relieve pain and inflammation. However, prolonged use raises the risk of heart and kidney failure events. A heart attack causes death of heart muscle cells by lack of oxygen, and it also significantly injures the kidneys.

7 Feb 2019

Researchers show efficacy of new therapy for amyotrophic lateral sclerosis in mice

A team from Université Laval and the CERVO Brain Research Centre has demonstrated the efficacy in mice of a new therapy that addresses the main manifestation of amyotrophic lateral sclerosis.

7 Feb 2019

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.

7 Feb 2019

New review examines impact of cancer therapies on the skeleton

A new British Journal of Clinical Pharmacology review examines the impact of cancer therapies on the skeleton and how to limit bone loss and fractures in cancer patients treated with these therapies.

6 Feb 2019

Drug cocktail may help combat breast cancer

MYC, a gene with high cancer-initiating potential, is overexpressed in over 40% of breast cancers. While MYC programs breast cancer cells to build more macromolecules (anabolic metabolism) it also creates a metabolic vulnerability by making them more sensitive to a type of cell death known as apoptosis.

6 Feb 2019

New study estimates prevalence and risk factors for misuse of prescribed opioids

A new Pharmacoepidemiology & Drug Safety study estimates the prevalence and risk factors for self-reported misuse of prescribed opioids in the general adult population.

6 Feb 2019

Pharmaceutical News

Marijuana edibles carry risk and side effects for patients with cardiovascular disease

MDMA users have higher levels of empathy than other drug users

New findings could provide novel approach to target and destroy cancer cells

New cancer drug that acts as ‘Trojan horse’ shows promise in patients with various cancers

'Trojan horse' drug shows promise for untreatable cancers

Misinformation is causing measles cases to rise worldwide

FDA takes initiative to adopt modern technologies for enhancing security of the drug supply chain

Drug that reverses blood thinning effects stops acute life-threatening bleeding

Study finds underutilization of aspirin to prevent colorectal cancer in high risk patients

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

Blood-clotting factor may cause Alzheimer's disease

Combination treatment lowers risk of ischemic stroke recurrence

New physical effect could lead to advancements in personalized pharmaceuticals

Review: Antibiotic development has increased, but inadequate

NSAID pretreatment promotes cardiorenal syndrome in heart failure

Researchers show efficacy of new therapy for amyotrophic lateral sclerosis in mice

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

New review examines impact of cancer therapies on the skeleton

Drug cocktail may help combat breast cancer

New study estimates prevalence and risk factors for misuse of prescribed opioids

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News